Dr Reddy's Laboratories has provided update on patent litigation with respect to generic Buprenorphine and Naloxone Sublingual Film in the U.S. Market.
The Judge has heard the matter on 28 June 2018 and extended the temporary restraining order for a further period of 14 days pending his decision.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
